In another instance, a panel of six biomarkers consisting of CA-125, osteopontin, leptin, prolactin, MIF and IGF-II improved the sensitivity at 95.3 % and specificity at 99.4 % for ovarian cancer detection (Visintin et al., 2008). This evidence concerns the gene MIF and ovarian carcinoma.